Life expectancy and economic impact of multiple sclerosis in an Australian setting


  • A health economics model of the progression of multiple sclerosis (MS) was developed and used to calculate the impact of MS on life expectancy (LE) and lifetime societal costs in Australia.

Why this matters

  • Health economic evaluations, such as LE and lifetime societal cost, are crucial in reimbursement decisions and evaluations of new medicines for MS.